# Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk Genotype

> **NCT01078870** · PHASE4 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 75 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Lexapro
- **DRUG:** Cymbalta
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01078870
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-02
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2010-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01078870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01078870, "Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk Genotype". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01078870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*